Immunogenicity of a new, inactivated canine adenovirus type 2 vaccine for dogs

Dong-Kun YANG; Ha-Hyun KIM; Jae-Young YOO; Miryeon JI; Bok-Hee HAN; Subin OH; Bang-Hun HYUN

Home > Búsqueda > ()

XML

| |

Immunogenicity of a new, inactivated canine adenovirus type 2 vaccine for dogs

Dong-Kun YANG; Ha-Hyun KIM; Jae-Young YOO; Miryeon JI; Bok-Hee HAN; Subin OH; Bang-Hun HYUN.

Clinical and Experimental Vaccine Research ; : 40-47, 2020.

Artículo en Inglés | WPRIM | ID: wpr-782293

0.05). Dogs inoculated with the former vaccine developed a significantly higher immune titer than non-vaccinated dogs.

CONCLUSION:

The Cabopol-adjuvanted, inactivated CAV-2 vaccine was safe and induced a high VNA titer in dogs.

Asunto(s)

Animales Perros Adenovirus Caninos Aminoácidos Ensayo de Inmunoadsorción Enzimática Formaldehído Cobayas Células de Riñón Canino Madin Darby Urea Vacunas

Biblioteca responsable: WPRO

Biblioteca Virtual en Salud

Hipertensión

Formato de exportación:

Immunogenicity of a new, inactivated canine adenovirus type 2 vaccine for dogs

CONCLUSION:

Asunto(s)